Company intelligence / Profile preview

daVIZta

Somerset, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

daVIZta was a private healthcare technology company focused on enterprise revenue analytics solutions and related services for the life sciences industry. Its software and services supported commercial-stage biopharma manufacturers with gross-to-net automation, government pricing, deal modeling, claims processing, and related payer and revenue management workflows. The company served large, mid-tier, and emerging life sciences manufacturers rather than developing therapeutics itself. In March 2019, daVIZta merged with and was acquired by IntegriChain, which integrated daVIZta's offerings into the ICyte platform. As a result, daVIZta appears to no longer operate as an independent active company.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

IntegriChain

Beyond the preview

Go deeper on daVIZta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on daVIZta.

Explore the full profile